These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19836865)

  • 1. Treatment of actinic cheilitis with imiquimod 5% and a retractor on the lower lip: clinical and histological outcomes in 5 patients.
    McDonald C; Laverick S; Fleming CJ; White SJ
    Br J Oral Maxillofac Surg; 2010 Sep; 48(6):473-6. PubMed ID: 19836865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod cream in the treatment of actinic keratoses.
    Persaud A; Lebwohl M
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential use of photodynamic therapy and imiquimod 5% cream for the treatment of actinic cheilitis: a 12-month follow-up study.
    Sotiriou E; Lallas A; Goussi C; Apalla Z; Trigoni A; Chovarda E; Ioannides D
    Br J Dermatol; 2011 Oct; 165(4):888-92. PubMed ID: 21916880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A topical imiquimod-induced oral mucosal lichenoid reaction: a case report.
    Brown RS; Farquharson AA
    J Am Dent Assoc; 2014 Nov; 145(11):1141-5. PubMed ID: 25359646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
    Sauder DN; Skinner RB; Fox TL; Owens ML
    Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Photodynamic therapy for actinic cheilitis].
    Castaño E; Comunión A; Arias D; Miñano R; Romero A; Borbujo J
    Actas Dermosifiliogr; 2009 Dec; 100(10):895-8. PubMed ID: 20038368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream.
    Cowen E; Mercurio MG; Gaspari AA
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S240-8. PubMed ID: 12271286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe reaction to 5% imiquimod cream with excellent clinical and cosmetic outcomes.
    Greenberg HL; Cohen JL; Rosen T; Orengo I
    J Drugs Dermatol; 2007 Apr; 6(4):452-8. PubMed ID: 17668546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 5% imiquimod for the therapy of actinic cheilitis.
    Smith KJ; Germain M; Yeager J; Skelton H
    J Am Acad Dermatol; 2002 Oct; 47(4):497-501. PubMed ID: 12271290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
    Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
    Diamantis ML; Bartlett BL; Tyring SK
    Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical imiquimod: mechanism of action and clinical applications.
    Vidal D
    Mini Rev Med Chem; 2006 May; 6(5):499-503. PubMed ID: 16719822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod reactivation of lichen planus.
    Domingues E; Chaney KC; Scharf MJ; Wiss K
    Cutis; 2012 Jun; 89(6):276-7, 283. PubMed ID: 22838091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod in clinical practice.
    Edwards L
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
    Gupta AK; Davey V; Mcphail H
    J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation and efficacy of Imiquimod 3.75% cream for the treatment of actinic keratosis, pigmented basal cell carcinomas, and actinic cheilitis.
    Paolino G; Cantoresi F; Mercuri SR; Cantisani C
    Dermatol Ther; 2020 May; 33(3):e13356. PubMed ID: 32239714
    [No Abstract]   [Full Text] [Related]  

  • 18. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head.
    Alomar A; Bichel J; McRae S
    Br J Dermatol; 2007 Jul; 157(1):133-41. PubMed ID: 17501955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.
    Kagy MK; Amonette R
    Dermatol Surg; 2000 Jun; 26(6):577-8; discussion 578-9. PubMed ID: 10848940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.
    Wagstaff AJ; Perry CM
    Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.